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ABSTRACT
DIRECT BINDING OF PAROTID SECRETORY PROTEIN TO
PHOSPHATIDYLINOSITOL PHOSPHATES
Dipti Goyal
October 25,2010
BACKGROUND: Regulated secretion of protein by salivary and other exocrine glands
requires correct trafficking of soluble cargo proteins into secretory vesicles. However, the
molecular mechanism of sorting in the parotid salivary gland is unknown.
Phosphatidylinositol phospholipids, such as Ptdlns(3,4)P2 , are present in the membrane
of secretory granules. We have shown that crude preparations of native Parotid Secretory
Protein (PSP) bind Ptdlns(3,4)P 2 ; however, it is unclear whether this is due to a direct
interaction.
HYPOTHESIS: We hypothesize that PSP directly binds Ptdlns(3,4)P2 with high affinity.
METHODS: Rat PSP cDNA with a C-terminal V5 tag was cloned into a glutathione-Stransferase (GST) expression vector. Conditions were optimized for expression and
purification of protein. The affinity purified protein was cleaved from the GST tag using
PreScission protease. To test for binding ofPSP to PtdlnsPs and quantify the binding
affinity, the bacterially expressed proteins were used for lipid-overlay binding
experiments with nitrocellulose membranes having lipid spots.
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RESULTS: GST-PSP-V5 was expressed in bacteria and purified with glutathione beads.
rPSP-V5 bound to Ptdlns(3,4)P2 with a 10-fold higher affinity than to Ptdlns(3,5)P2 or
Ptdlns(4,5)P2 and showed minimal binding to Ptdlns(3,4,5)P 3 . No binding ofrPSP-V5
was observed with Ptdlns or Ptdlns(3)P. The other proteins known to bind specifically to
Ptdlns(3,4)P2 are TAPPI and p47 phox. Protein-lipid overlay assays found stronger binding
of bacterially expressed rPSP than p47 phox to Ptdlns(3,4)P 2. rPSP-V5 bound Ptdlris(3,4)P2
with an affinity ofKd = 30 pM. Bacterially expressed human PSP (Splunc 2) also bound
to PtdlnsPs with a lipid specificity similar to the rat PSP.
CONCLUSION: Binding of bacterially expressed affinity purified rat PSP to
Ptdlns(3,4)P2 indicates that PSP binds directly to PtdlnsPs. The

K! value shows that rPSP

has a high binding affinity for Ptdlns(3,4)P2. These results suggest that the observed
binding of rat PSP to granule membranes may be by a direct interaction with PtdlnsPs.
We demonstrate for the first time that human PSP binds to the headgroup of
Ptdlns(3,4)P2.
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INTRODUCTION
PAROTID GLAND
The Parotid gland is one of the major salivary glands. It secretes salivary proteins
including amylase, Parotid Secretory Protein (PSP), a family of Proline-Rich Proteins
(PRPs) and less abundant proteins such as histatin and statherin [1]. Salivary proteins
play an important role in host defense. They have antibacterial properties and have
digestive functions like moistening food and helping in creating the food bolus. Peptides
derived from PSP have been reported to have both antibacterial and anti-inflammatory
properties making it an important salivary protein [2, 3]. PSP also has been shown to
have anticandidal properties [4]. The parotid gland is the largest salivary gland and the
most frequent disorder associated with it is Sjogren's Syndrome, which affect 1-3% of
the population, having a frequency of 1:5000 [5]. It leads to dry mouth and eyes as it is an
inflammatory disease of exocrine glands. Xerostomia is the primary symptom of
Sjogren's syndrome because of salivary gland hypofunction [6]. The salivary flow rate
from the parotid gland in Sjogren's Syndrome falls to 0.291 mLiglandimin from a normal
value of 0.672 mLigland/min [7], predisposing the patient to increased dental carles, and
increasing the virulence of bacterial and fungal infections [8]. Many of these symptoms
are due to the loss of salivary proteins, therefore it is important to understand the
mechanism of protein sorting.
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MECHANISMS OF PROTEIN SECRETION
Regulated secretion of protein by salivary, pancreatic and endocrine glands
requires the correct trafficking of soluble cargo proteins to the final destination. These
cargo proteins are transported by vesicles termed 'secretory granules' which are formed
at the trans-Golgi network (TGN) of the Golgi apparatus [9]. Secretory proteins are
predominantly stored at high concentrations in the dense core secretory granules of both
exocrine and endocrine glands [10].
Multiple potential post-Golgi pathways exist for intracellular trafficking of these
secretory proteins. The major pathway in exocrine cells is the Regulated Secretory
pathway wherein cargo proteins are stored in intracellular dense core granules until an
extracellular stimulus is received to stimulate their release at the apical membrane of the
cell [11]. It accounts for 80-90% of the salivary secretion from the parotid acinar cells
[1]. Regulated secretion targets the cargo proteins to the apical surface and into the oral
cavity. Alternatively, the constitutive pathway, which is common to all eukaryotic cells,
secretes protein in the absence of any stimulation. The constitutive secretory pathways
allow secretion from both the apical and basolateral (into the circulation) cell surfaces [1,
11-13]. The other secretory pathways are the minor regulated secretory pathway
originating from maturing secretory granules, and the constitutive-like secretory pathway
originating from secretory granules but not requiring any stimulation [1]. These latter
two pathways are thought to be present based on kinetic arguments, and may contribute
to salivation in the absence of neural stimulation. Given the presence of multiple
pathways, the acinar cell must have a mechanism for sorting and trafficking (sorting)
salivary proteins into the apical regulated pathway, and away from the basolateral
2

constitutive pathways. Any cargo proteins (such as amylase) in the basolateral pathways
are secreted eventually into the bloodstream, and are lost to the saliva.
PROTEIN SORTING
Delivery of the cargo proteins to specific post-Golgi vesicles involves processes
collectively termed "Protein Sorting" [14-16]. It involves selective entry of the protein
into the correct immature vesicle and retention of the protein as the vesicle matures [9,
17]. The vesicles containing the proteins from the trans-Golgi network (TGN) traffick
them to their correct final destinations [18]. The TGN of all cells produce vesicles for
multiple specific destinations, either to the cell surface or directed to intracellular
compartments such as endosomes or lysosomes. Hence, correct protein sorting is a
function that must be fulfilled by all cells from yeast to mammals. Cargo proteins
destined for exocrine secretion into saliva must be sorted into the correct vesicles that
will enter the Regulated Secretory pathway.
Two models have been suggested for protein being sorted into the vesicles from the
trans-Golgi network. One is "sorting by entry", according to which protein gets sorted
directly into the vesicle from TGN [17]. This could be derived from pH/Ca++ aggregation
[19], or by association of protein with the lipid rafts present in the trans-Golgi network or
the protein aggregate complex binding to the TGN membrane [20]. Thus for sorting into
immature vesicles, aggregation is required [21]. The other model suggests "sorting by
retention" for which all proteins enter the immature secretory granule unsorted, and the
correct cargo proteins are retained in the vesicles as the vesicle matures and other
proteins are removed during vesicle maturation [22]. Little has been done to distinguish
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between these models, but importantly both require sorting of the soluble cargo proteins
at some point.
Sorting of specific cargo proteins has been suggested to require a membrane
sorting receptor. Sorting receptors have been identified in pancreas and other tissues, but
no sorting receptor is known in the parotid gland. There are a variety of receptors present
on the vesicles which help in sorting of specific cargo proteins, for example,
carboxypeptidase present on the vesicle membrane helps in sorting of ACTH in pituitary
cells [9]. Secretogranin III has been shown to be a sorting receptor for chromogranin in
pituitary and pancreatic Bcells [23]. However, no such sorting receptor has been reported
for Parotid Secretory Protein (PSP), or for any other parotid protein. Also the pH "and
calcium induced protein aggregation leading to sorting of protein into secretory granules,
as seen is endocrine cell lines [24] and exocrine pancreatic secretory granules [25], is not
present in exocrine parotid gland protein sorting. It has been reported that the parotid
secretory granule protein do not aggregate in vitro under high or low calcium corrditions
or at different pH conditions [19, 26].
Therefore, the mechanism of sorting of salivary proteins in the parotid is
unknown. The key issue is to understand the molecular interactions of the proteins
destined for regulated secretion, which cause sorting to the correct immature granule as it
forms, or which cause retention of the protein in the granule as it matures.
To investigate the mechanism of sorting of protein into parotid secretory granules,
the interaction of salivary cargo proteins with rat parotid secretory granule memb!anes
was studied. PSP was the only major cargo protein that bound to the secretory granule
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membrane. The other major salivary proteins, Proline-Rich Protein (PRP) and amylase,
did not bind to the membranes. Subsequent experiments in Dr. Darling's laboratory found
that PSP in crude extracts of parotid granules is able to bind to a rare membrane lipid,
phosphatidylinositol (3,4)bis-phosphate (Ptdlns(3,4)P2). This is consistent with the role of
phosphatidylinositol phosphates in anchoring proteins to specific regions of membranes,
leading to trafficking of the protein [27]. Phosphoinositide-binding domains play critical
roles in the intracellular localization of a variety of cell signaling proteins. The binding of
PSP to Ptdlns(3,4)P2 may contribute to sorting in the parotid, however, PSP lacks a
recognizable phosphoinositide-binding domain, and may interact with membrane lipid
through another protein. Therefore, it is necessary to purify PSP to demonstrate direct
high affinity binding to Ptdlns(3,4)P2.
PHOSPHOINOSITOL PHOSPHOLIPIDS
Phospholipids form the bilayer of the cell membrane. One of the key constituents
of the cell membrane is phosphatidylinositol (Ptdlns). Its phosphorylated derivates are
called phosphoinositides (PtdlnsPs). There are 7 different phosphorylated forms OfPtdlns
due to different combinations of phosphorylation of 3 sites on the inositol ring (Figure
1). Phosphatidylinositol is a rare lipid constituting 1% of the total lipids [28].
Phosphorylated phosphatidylinositols constitute only 0.1 % of the total lipids present in
the eukaryotic cell [28]. Of the phosphoinositides, Ptdlns(4)P and Ptdlns(4,5)P2 are the
most abundant, however, they are present as only 0.05% of the lipid [28]. Alternatively,
Ptdlns(3,4)P2 is of very low abundance, comprising only 0.0001% of membrane lipids.

5

The synthesis of specific phospholipids is geographically restricted to certain
membranes. The metabolism of the lipid determines its composition in an organelle.
PtdIns(4,5)P2 is present mainly at the plasma membrane. It plays an important role in
endocytosis, by recruiting selective proteins (two subunits of the AP2 complexes, AP180,
CALM, epsin) to the plasma membrane [29]. Alternatively, PtdIns(3)P is predominantly
present on endosome membranes. Many endosomal proteins such as Hrs and SARA
contain PtdIns(3)P-binding domains (such as the FVYE and PX domains) which are
required for localization to the endosome [30]. Similarly, PtdIns(4)P is localized to TGN
complex, and is responsible for localization of specific proteins. PtdIns(3,4)P 2 is found
mainly in the early endocytic pathway and plasma membrane [31]. The lipid components
of the parotid secretory vesicles have not been reported.
Phosphoinositides directly affect membrane trafficking in all cells, which was
first studied in yeast [32]. PtdIns(3)P has been shown to play an important role in
membrane trafficking from Golgi to endosomes. There are many phosphoinositide
binding modules which have been identified in numerous proteins. These
phosphatidylinositol (PtdIns) phospholipids act as major determinants in localizing
protein to their site of function by binding of specific domains of protein. For example,
the interaction of the PX domain ofVam 7 with PtdIns(3)P targets it from the TGN to the
yeast vacuole [33]. PX domains (120 amino acids) have been identified in more than 100
proteins. In proteins like Vam 7 [33] ,p47phox [34], and SNX3[35] the PX domain binds
to PtdIns(3)P targeting the proteins to their final destination. The interaction ofPX
domain containing proteins with PtdInsPs is important in protein sorting, vesicular
trafficking and phospholipid metabolism [36]. There are many other PtdInsP- binding
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motifs such as PH (Pleckstrin homology) [37], FYVE [38], and ENTH (Epsin NH2 terminal homology) [39]. The ENTH domain interacts specifically with Ptdlns(4,5)P2
leading to clathrin mediated endocytosis. Ptdlns(3,4)P2 is bound by the PX domain of
p47 phox [34, 40] and PH domain ofTAPP1 and TAPP2 [41-44]. It is the combination of
the protein and lipid which ensures proper localization ofthe protein and therefore proper
function of the protein.
There are a number of human diseases which are linked to defects in PtdlnsP
signaling, including cancer and immunodeficiency disorder (X-linked
agammaglobulinemina). Mutations in p47 phox, including its PX domain, cause
granulomatous disease [45]. These mutations interrupt the interaction with Ptdlns(3,4)P2
leading to chronic granulomatous disease. Signaling defects in Ptdlns(4,5)P 2 contributes
to human pathologies like cardiac failure, bipolar disorder and the genetic disorder Lowe
syndrome [46].

7

Figure 1: Structure of Phosphoinositides.
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IMPORTANCE OF PROTEIN SORTING
It is important to understand protein sorting mechanisms. The parotid and
/

submandibular glands have been suggested to be opportune sites for production of
therapeutic transgenic peptides [48]. Also, since the regulated secretory pathway requires
sorting signals, the peptide hormones for which no sorting signal have been devised,
when transfected into the salivary gland takes a default pathway of constitutive secretion
and gets secreted in blood stream. Considering this, a glucagon-like peptide was
delivered systemically by gene transfer into salivary gland [49]. Salivary glands have
also been used as the target sites for delivery of a therapeutic protein beneficial for oral
cavity and upper GI tract. An Anti-candidal peptide c-DNA for histatin 3 was expressed
in rat salivary gland and the transgenic gene produced was used against Candida albicans
[50]. However, proteins that are normally secreted in an endocrine fashion, when placed
into the salivary gland can enter the secretory pathway into the oral cavity, which is not
therapeutically useful. Salivary glands are targets for gene transfer for protein deficiency
syndromes such as involving growth hormone [51]. Failure to redirect the secretion of
human growth hormone by the salivary gland from the regulated secretory pathway (into
the saliva) to constitutive secretion (into the bloodstream) shows the inability to
manipulate the regulated secretory pathway [52], as the mechanisms by which proteins
are sorted to either secretory pathway are still not understood. Thus, increased
understanding in secretory protein sorting will help in using salivary glands more
efficiently as gene therapeutics.
The key issue is to understand the molecular interactions of proteins destined for
regulated secretion, interactions which cause sorting to the correct immature granule as it
9

forms, or which cause retention of the protein in the granule as it matures. PSP is .one of
the most abundant proteins in parotid saliva. Thus it is important to identify the
mechanism of sorting of parotid secretory protein (PSP) in the parotid gland. My
hypothesis is that In vitro purified Parotid Secretory Protein binds with a high affinity to
PtdIns(3,4)P 2. To study this, rat PSP and human PSP were bacterially expressed and
purified and binding studies were done using a protein-lipid overlay assay.

10

METHODS
CONSTRUCTION OF PLASMIDS EXPRESSING FUSION PROTEINS
In order to study the in vitro protein purification of rat PSP (rPSP) and its .binding
affinity with the lipids, it was essential to express it as a fusion protein. Fusion vectors
such as pGEX allow inducible and high level intracellular bacterial production of fusion
proteins, and limit the formation of inclusion bodies. These vectors have been constructed
to produce proteins of interest in E.coli as C-terminal fusions with the 26 kDa
glutathione-S-transferase (GST) protein [53]. A GST-rPSP fusion expression plasmid

(Figure 2) was constructed by PCR. Since the mature PSP protein normally does not
have the endoplasmic reticulum signal sequence, this 21 amino acid peptide was not
included in the clones, which were termed deltaSS (dSS). A 14 amino acid V5 ep!tope
was added to the C terminal end ofrPSP to provide a tag for binding ofthe anti-V5
antibody, to identify and quantify the presence ofthe protein. The rPSP cDNA sequence
was amplified by PCR using a cDNA clone of rat PSP as the template and primers which
introduce unique flanking restriction enzyme sites. The two primers are: rPSP-EcoRev
(5'- CAC CGA ATT CTC AGA GAG GGA CTG CTA GCT C-3') and BamPSPFor (5'CAC CGG ATC CCT TCT TGG TGA CGT TGC C-3') primers. Amplification was
carried out for 30 cycles consisting of denaturation at 95°C for 10 minutes, annealing at
67°C for 45 seconds and extension at noc for 120 seconds. The PCR product w~s
confirmed by agarose gel electrophoresis and purified from the gel by Qiagen QIAquick
11

Gel Extraction Kit (as recommended by the manufacturer). The amplified fragment of
rPSPdss and the pGEX expression vector were digested with BamHI and EcoRI enzyme
and ligated. The mixture was then transformed into TI0 competent cells and clone DNAs
were extracted from bacterial colonies by miniprep. The plasmids were sequenced at the
University of Louisville CGeMM Sequencing core, after which the correct clones were
transformed into BL21 one shot star (DE3)pLysS competent bacteria. The pLysS plasmid
carried by the BL21 (DE3)pLysS strain produces T7lysozyme to reduce basal level
expression of the gene of interest. The GST protein encoded in the pGEX vector (without
rPSPdss) was also tagged with V5 antigen to be used as a control. Table 1 and Figure 4
shows the final clones fabricated and used for these experiments.
VERIFYING BACTERIAL EXPRESSION OF PSP
Individual colonies were inoculated in 10 mL of fresh LB medium along with
ampicillin (0.1 mg/mL) and were incubated overnight at 37 0 C in a shaker (Environ Orbit
shaker). An overnight culture (1.5 mL) was inoculated in fresh 5 mL LB medium. The
culture was incubated at 37 0 C until an optical density of 0.8 was reached. 20 JlL of
sample was taken from the uninduced bacterial culture and centrifuged at 20,000 rpm for
5 minutes in a Beckman 22R centrifuge. The supernatant was discarded and the pellet
was resuspended in SDS-PAGE sample buffer. Isopropyl

~-d-thiogalactopyranoside-

.

(IPTG) of 0.1 mM final concentration was added and incubated again at 37 0 C for
additional 4 hours. IPTG specifically activates the expression of GST protein (or the
GST-PSP protein) from the pGEX vector. To study the effect ofIPTG at various time
intervals, aliquots of induced bacterial culture were taken at different times over a period

.
of 4 hours (15 mins, 30 mins, 45 mins, 1 hr, 2 hr, 3 hr, and 4 hr). All the samples were
12

centrifuged and the pellet was resuspended in the SDS-PAGE buffer. The samples were
electrophoresed by SDS-PAGE and transferred onto a ployvinylidene fluoride (PVDF)
membrane via western blotting. The membrane was probed with anti-V5 antibody to test
for the expression of the protein.
LARGE SCALE EXPRESSION
To express large amounts of fusion protein, 50 mL of fresh LB medium was
inoculated with the glycerol stock of the clone and incubated overnight at 37°C in
Environ Orbit shaker. 2 mL of the overnight culture was added to a fresh 100 mL of LB
medium and incubated at 37°C in a shaker till the optical density of 0.8 was reached.
IPTG was added to the final concentration of 0.1 mM and incubated further for 2 hours.
The induced bacterial culture was centrifuged at 4000 rpm at 4°C in GH 3.8 rotor. The

.
supernatant was discarded and the pellet was washed in 5 mL of ice cold phosphate
buffered saline (PBS: 140 mMNaCI, 2.7 mM KCI, 10 mM Na2HP04, 1.8 mM KH 2P 4,
pH 7.3) and 1 mM phenylmethyl-sulfonyl fluoride (PMSF). The pellet was stored at20°C for future use.

13

Figure 2: Plasmid map of pGEX-rPSP

~

\" ".,."...

Figure 2: The rPSP cDNA was cloned into the pGEX expression vector. Expression
vectors used were pGEX 4T-3 and the pGEX 6P-1. All the clones were tagged with a
V5 antigen.
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PURIFICATION OF THE BACTERIALLY EXPRESSED PROTEIN
A. SMALL SCALE
The IPTG induced bacterial pellet (from 5 mL of bacterial culture; stored at 20°C) was resuspended in 5 mL of ice cold PBS along with 1 mM PMSF, 1 uM protease
inhibitor cocktail (Protease inhibitor cocktail tablets- Roche Diagnostics), 5 mM
dithiotheritol (DTT) and 1 mM ethylenediaminetetraacetic acid (EDTA). To the lysis
buffer an ionic detergent, N-Laurylsarcosine (sarkosyl) (different concentrations, 0%,
0.25%,0.5%, 1.0% and 1.5%) were added to solubilize the protein as most of the protein
was initially seen in the inclusion bodies. The lysed cells were sonicated for 4 cycles of
10 seconds each with duty cycle 2 and output 3. Sonication waS carried out on ice
(Branson Sonicator). It was followed by centrifugation at 18,000 x g for 20 min in a
Beckman 22R centrifuge. The supernatant (bacterial lysate) was incubated with
Glutathione Sepharose beads to allow affinity binding of the GST to the glutathione.
Washed glutathione Sepharose 4B was made a 50% (v/v) slurry in PBS. Aliquots (500
~L)

of the bacterial lysate were incubated with different volume of the glutathione

Sepharose beads (20

~L,

60

~L,

90

~L,

150 ~L and 200

~L)

at 4°C for an hour with

constant end-to-end mixing. A separate set of aliquots were incubated at room
temperature (24°C) for an hour to test the temperature which gives maximum binding to
the beads. Incubation was done with continuous agitation and later centrifuged at 1000g
for 1 minute. To increase the amount of protein binding to the beads, Triton X-IOO (0%
to 2%) was added during the incubation of protein with beads. The protein bound to the
beads was washed 5 times with 10 bed volumes of ice cold PBS along with 1 mM PMSF.
The beads were washed for 10 minutes with end to end mixing at 4°C followed by
15

centrifuging at 1000g for 1 min. Elution buffer (5 mM, 15 mM, 30 mM or 50 mM
reduced glutathione) were added to the washed glutathione Sepharose beads in elution
buffer (5 mM DTT, 1 mM EDTA and 50 mM Tris at pH 8) to specifically elute the
bound GST-fusion protein. After 1 hr of incubation at room temperature with mild
agitation the eluted protein was obtained by centrifuging the beads at 5000 x g for 5
minutes. For storage, glycerol was added to the final concentration of 10% and the
glutathione-eluted protein was placed at -80 degree C.

LARGE SCALE PURIFICATION
The induced bacterial culture (100 mL) in pellet form which had been stored at20oe, was resuspended in 5 mL of the lysis buffer (IX PBS, 0.25% sarkosyl, 5 mM DTT,
1 mM EDTA, 1 mM PMSF, 50 mM Tris, pH 8) and sonicated 4 times for 10 sec each
while resting on ice. The sonicated bacterial culture was centrifuged at 18,000 x g for 30
min in a Beckman 22R centrifuge. The bacterial lysate supernatant (I.5 mL) was
incubated with 200 JiL of glutathione Sepharose 4B, 50% (v/v) for an hour at 4°e with
continuous agitation. After centrifuging at 1000 x g for 1 minute, the protein bound to the
beads was washed with 10 bed volumes of washing buffer. The beads were washed 5
times to remove the non-specifically bound proteins. Each washing cycle lasted for 10
minutes at 4°e with continuous mixing followed by centrifugation at 1000g for 1 minute.
The buffers used for each wash were as follows:

•

1st and 5th wash: IX PBS + 1 mM PMSF + 5 mM EDTA

•

2nd and 3rd wash: IX PBS + 5 mM EDTA + 5 mM EDTA + 5 mM ATP + 5 mM
MgS04 + 0.1 mg/mL denatured E.coli + 50 mM Tris, pH 7.5
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•

4th wash: 5 mM ATP, 5 mM MgS04, 0.1 mg/mL Denatured E.coli, 50 mM Tris,
pH 7.5,350 mM NaCI
Washing was followed by incubation with 200 ilL of the elution buffer (15 mM

reduced glutathione, 1 mM EDTA, 1 mM DTT, 50 mM Tris, pH 8). Elution was carried
out for an hour at room temperature with mild agitation. Eluted protein (in the

.

supernatant) was obtained by centrifuging at 5000 x g for 5 min.
CLEAVGE OF GST FUSION PROTEINS
THROMBIN CLEAVAGE
rPSP was expressed in pGEX 4T-3 vector which contains a thrombin cleavage
site (Figure 3). Thrombin permitted cleavage of the rPSP protein from the GST tag. After
washing the glutathione Sepharose beads, varying units of thrombin were added (ranging
from 0 U to 20 U) and incubation was carried out at 25°C for 4 hours to 16 hours.with
mild end to end mixing. The cleaved protein was obtained by centrifuging the mixture at
3000 rpm for 4 minutes.
PRESCISSION PROTEASE CLEAVAGE
The pGEX-6P expression vectors also permit convenient site-specific cleavage
(Figure 3). Cleavage ofrPSP from the GST portion of the fusion protein was carried out
with PreScission Protease. 200 ilL of 50% (v/v) glutathione Sepharose slurry was treated
with 20 units (10 ilL) of Pre Scission protease enzyme in the cleavage buffer (50 mM
Tris, 150 mM NaCI, 1 mM EDTA, 1 mM DTT, ph 7.0) for 4 hours at 4°C with end to
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end mixing. The cleaved protein was eluted by centrifuging at 500 x g for 5 min. Purified
protein cleaved from the GST tag was stored at -80°C.
GEL ELECTROPHORESIS AND WESTERN BLOTTING
Protein samples were analyzed using 4-12% acrylamide SDS-PAGE and imaged
by silver staining, or staining with Coomassie Blue R250. Silver staining was done using
the Thermo Scientific Pierce Silver Stain Kit. The image of the gel was captured on the
Kodak imagestation.
Alternatively, proteins were detected by western blotting with specific antibodies.
Protein in PAGE gels were transferred to PVDP membrane which was blocked with
TTBS containing 2% Tween-20 for 20 min followed by overnight incubation with antiV5 antibody (Invitrogen R 960-25) (l :5000 dilution). The next day, the membrane was
washed with TTBS for an hour, followed by incubation with a 1:5000 dilution of HRPconjugated anti-mouse IgG antibody. The signal was detected by Pierce
chemiluminiscent mix on Kodak image station. The membrane was also probed with
anti-PSP antibody. Relative optical instensities (ROls) of the detected protein were
recorded on the Kodak Imagestation. Analysis is performed using the pixel information
on either the perimeter or on the interior contents of the band.

18

Figure 3: Restriction Cleavage sites present in the pGEX expression vector.
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Figure 3: pGEX 6P-l has the PreScission Protease cleavage site and the pGEX4T-3
has the Thrombin cleavage site. The rPSP was inserted in between the BamHl and
EcoR 1 restriction sites.
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PROTEIN-LIPID OVERLAY ASSAY
DIFFERENT CONCENTRATIONS OF PHOSPHOINOSITIDES
The ability of the PSP or GST-PSP fusion proteins to bind a variety of
phosphoinositides was analyzed using a protein-lipid overlay assay. Lipid solution (1 ilL)
containing 6.25 - 200 pmole of Phosphoinositides dissolved in chloroform!
methanol/water (1/2/0.8) was spotted on Hybond-C-extra nitrocellulose membranes and
dried at 4 DC for 1 h. This created an array of spots with different concentrations of
specific PtdInsPs. The membrane was blocked with 0.01% fat-free BSA in PBST (PBS,
0.1% Tween 20) pH 7.0 at room temperature. The membrane was incubated with 1
Ilg/mL ofrPSP-V5 in the same buffer. Some experiments were blocked with PBST +
0.25% Tween (no BSA), and incubated with rPSP-V5 in PBST. After washing the
membrane six times in PBST buffer, it was incubated with anti-V5-HRP antibody
(Invitrogen) (1 :5000 dilution) for 1 h. The membrane was then washed six times with the
PBST buffer and the signal was detected by Pierce chemilurninescent mix on the Kodak
Imagestation. Relative Optical Intensity (ROI) was recorded for the protein bound to the
phospholipids.

DIFFERENT CONCENTRATIONS OF PROTEIN
As an alternative experimental design, binding was quantified using a series of
incubations with different concentrations ofPSP-V5 protein. Nitrocellulose membrane
was cut into 0.75 x 0.75 cm squares. They were spotted in duplicate with lipid soTution (1
ilL) containing 50 pmole ofPtdlns or Ptdlns(3, 4)P2. After drying the membrane for 1 h
at 4DC, blocking was done with PBST containing 0.01 % fat free BSA (Blocking buffer)
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for 1 h. The membranes were incubated separately in the blocking buffer containing 0.1
to 3.5 Jlg/mL ofrPSP-V5 at room temperature. After 1 h incubation, the protein solution
(free protein) was saved. All the membranes were washed with PBST six times and
incubated with anti-V5 HRP antibody (1 :5000) dilution for 1 h in PBST buffer.
Membrane was washed for 1 hour and the signal was detected by Pierce
chemiluminescent mix on Kodak Imagestation.
Since the goal of these experiments was to measure the binging of rPSP to lipids,
it was important to quantify both the bound and free protein. To do this a standard curve
was created by spotting known amounts ofrPSP-V5 on to a nitrocellulose membrane.
After protein incubation, free protein was spotted in duplicate on the

nitrocellulo~e

membrane. Both the membranes were air dried and blocking was done with PBST +
0.25% Tween for 1 h. This was followed by one hour incubation with anti-V5 HRP
antibody. The membranes were washed six times for 1 h with PBST. ROls for the rPSPV5 were recorded on the Kodak Imagestation. The bound and the free protein
concentrations were calculated using the standard curve.
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RESULTS
CONSTRUCTION OF CLONES

The clones created for this work are listed in Table 1 and Figure 4. Each pGEX
clone was designed to express a GST fusion protein. Names of each fusion protein used
in this study are listed in Table 1, column 5. All the clones showed the correct sequence
and were successfully transformed into BL21 (DE3)pLysS competent cells. These
clones were further confirmed by determining that the correct size GST fusion protein
was expressed (Figure 5).
INDUCTION OF pGEX 4T-3-rPSPdss-V5 by IPTG

To test the expression of the GST-rPSP-V5 in E. coli BL-21 harboring pGEX 4T3-rPSPdss-V5, each of the clones were induced with IPTG (Isopropyl

~-D-I

thiogalactopyranoside). The bacterial cultures ofpGEX 4T-3-rPSPdss-V5, pGEX 4T-3Human PSPdss-V5, pGEX 4T-3-Human PSPdss-V5 and pGEX 4T-3-V5 (see Table I)
were induced with IPTG. An overnight culture of bacteria was diluted 1:5 in fresh
medium and incubated at 37°C until the bacterial culture reached log phase [53]. Before
adding IPTG an aliquot of the bacterial culture was taken (uninduced sample). The
uninduced sample acts as a negative control since without adding IPTG there should be
no expression of protein.
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The remainder of the culture was induced with 0.1 mM IPTG for 2 hours. Figure 5
shows a western blot probed with anti-V5 antibody. The samples were run on SDSPAGE. It can be seen that the uninduced lanes show no expression of protein as
compared to the bands present in the induced lanes, which confirms the induction of
GST-PSP-V5 fusion protein by IPTG.
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Table 1: List of the clones for studying the expression and binding of Parotid
Secretory Protein to PtdIns(3,4)P2_
PROT~IN

EXPR~:SSION

INSERT

TAG

pGEX4T-3

rPSPdss

attB V5

pGEX4T-3

No insert

attB V5

pGEX 6P-l

rPSPdss

attB V5

pGEX 6P-l

No insert

attB V5

FINA.L CLONE

VECTOR

HumanPSP
pGEX4T-3

pGEX4T-3

full length
HumanPSPdss

pGEX 4T-3ratPSPdss-V 5

NAME

GST-rPSP-V5

.

pGEX 4T-3-V5

GST-V5

pGEX 6P-l-

GST-2-rPSP-V5

ratPSPdss-V5

attB V5

attB V5

pGEX 6P-I-V5

GST-2-V5

pGEX 4T-3-Human

GST-hPSP(FL)-

PSP-V5

V5

pGEX 6P-l-

GST-hPSP-V5

HumanPSPdss-V5

24

Figure 4: GST -rPSP-VS recombinant proteins

A
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PSP

B

GST

T

GST-2

p

PSPdss

PSPdss

VS

VS

Figure 4: A: A cartoon ofthe original Parotid Secretory Protein (PSP) with the native

signal sequence (ss) attached to it. B: The structure of GST-PSP-V5 fusion protein, with
PSPdss fused to the GST protein along with a 14 amino acid V 5 antigen tag. PSPdss has
the N terminal sorting sequence deleted. The arrow indicates the location of the protease
cleavage site present in the GST expression vectors. GST-PSP-V5 has the arrow
indicating the Thrombin (T) cleavage site. In GST-2-PSP-V5 the arrow indicates the
PreScission (P) Protease cleavage site. Clones expressing rat or human PSP were
constructed with the pGEX expression vectors.
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Figure 5: IPTG induction of GST fusion protein.
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GST-rPSP-V5 GST-humanPSP-V5
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Figure 5: Aliquots (40 f.lL) of the induced (0.1 mM IPTG) and uninduced bacterial
cultures of GST-rPSP-V5 , GST-hPSP-V5 and GST-V5 were taken and centrifuged.
Samples were electrophoressed by SDS-PAGE followed by transfer to PVDF membrane.
The membrane was probed with anti-V5 antibody. Lane 1, 3, 5, 7; Uninduced. Lane 2, 4,
6, 8; Induced. Lane 5 and 6 are the uninduced and induced for GST-hPSPdss-V5 (dssdeleted signal sequence). Lane 7 and 8 are uninduced and induced for GST-hPSP(FL)-V5
(FL- full lenght).
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The expected sizes of all the expressed proteins are seen. GST-V 5 is 28 kDa, GSTrPSPdss-V5 is 54 kDa, GST-HumanPSPdss-V5 is 55 kDa and GST-HumanPSP full
length-V5 is 57 kDa.
In addition, the anti-V5 antibody detected a smaller protein apparently created by
partial degredation of the expressed fusion protein. The presence of the C-terminal V 5
tag, and the size of the protein indicates that it is produced by proteolytic cleavage within
the GST portion of the fusion protein. Due to the presence of this protein additional
experiments were done to optimize expression of the full length GST-PSP-V5 protein.
The goal of the next experiment was to define which concentration of IPTG
would induce maximum expression of protein. To test this, bacterial cultures were
induced with different concentrations of IPTG (0.1-1.0 mM). Before inducing with IPTG,
an aliquot of the bacterial culture was saved as the uninduced sample (negative control).
After IPTG induction for 2 hours, 40ul of sample was taken from each induced bacterial
culture. All the samples were centrifuged, and the pellet obtained was resuspended in the
SDS-PAGE buffer. The samples were electrophoresed on a 4-12% acrylamide SDSPAGE. Figure 6 is a western blot probed with anti-V5 antibody. It can be seen that IPTG
is necessary to induce expression, however, there is no significant difference in the
expression of the protein between 0.1 mM and 1.0 mM IPTG induction. The expected
size of the rPSPdss expressed as fusion protein with GST is 50 kDa. From this
experiment onwards, I decided to induce the protein expression with a final concentration
of 0.1 mM IPTG [53].
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Figure 6: Expression of GST -rPSP-V5 fusion protein.
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Figure 6: E.coli BL-21 containing the plasmid pGEX 4T-3-rPSPdss-attB VS were grown
at 37°C, until the optical density reached 0.8 and then induced with 0.1 mM to

1.0 mM

IPTG. Aliquots of the induced and uninduced bacterial culture were taken and
centrifuged. Samples were analyzed by electrophoresis on SDS-PAGE. The gel was
transferred to PVDF membrane for western blotting, followed by probing with anti-VS
antibody. Lane 1: uninduced (before adding IPTG). Lane 2-6: GST-rPSP-VS induced
with IPTG. M: Molecular size marker
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The optimal duration of IPTG induction varies with different proteins. Once the
bacterial culture has grown to log phase, it is induced with IPTG to express the protein
and incubation is done for different times depending on the clone. In all the experiments
above, the IPTG induction time had been kept constant as 2 hours. However, it was
necessary to determine the induction time which gives a maximum expression of GSTPSP protein. Therefore, an overnight culture was diluted with fresh LB medium and
incubated till the optical density reached 0.8, when it was induced with O.lmM IPTG for
different times and samples taken as described above.
The amount of protein expressed after induction increased with the increasing
time. Figure 7 is a western blot of the SDS-PAGE probed with anti-V5 antibody. As seen
from the figure, there is not a significant difference in the amount of protein expressed
from 45 minutes and beyond. According to standard IPTG induction protocol, induction
time should fall between 2 hours to 6 hours. Looking at the figure, I decided to keep the
induction time at 2 hours. The above experiment was repeated three times to carefully
define the optimum IPTG induction conditions.
My experiments demonstrated that GST fused rPSPdss was produced after IPTG
induction in BL21 (DE3) bacteria. I found that induction with O.lmM IPTG for 2 hours
gave the maximum yield of expressed fusion protein.
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Figure 7: Time course of protein expression after induction.
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Figure 7: An overnight culture of cells transformed with pGEX 4T -3 was added to 10
mL of fresh medium, grown for 120 min and 0.1 mM IPTG added. Samples (20 ilL)
were taken at the times indicated and analyzed by SDS-PAGE, followed by western blot
and probing with anti-V5 antibody. Lanes A to D: GST-rPSP-V5 induced for different
times.
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SOLUBILIZATION OF GST FUSION PROTEINS BY IONIC DETERGENTS
Initial attempts to purify the protein were not successful as most of the GST
fusion protein produced was partially or completely insoluble, likely due to formation of
inclusion bodies. Therefore my next goal was to solubilize the protein into the
supernatant. Addition of Sarkosyl to the lysis buffer has been effective in solubilizing
protein from inclusion bodies at an early centrifugation step after cell lysis [54].
Therefore, five sets of induced bacterial pellets were resuspended separately in lysis
buffer containing five different concentrations of sarkosyl (0%, 0.25%, 0.5%, 1.0%, and
1.5%). Following sonication and centrifugation, the pellet obtained was resuspended in
SDS-PAGE buffer. The samples were analyzed by SDS-PAGE and western blotting
probed with anti-V5 antibody (Figure 8). Comparison oflanes 1 and 2 shows that
addition of sarkosyllargely solubilized the protein from the pellet. The sample with no
sarkosyl had the maximum insoluble protein present. However, increasing the sarkosyl
from 0.25% to 1.5% did not further decrease the amount of protein present in the
inclusion bodies. As seen from the graph in Figure 9, there is a 6 fold decrease from 0%
sarkosyl to 0.25% sarkosyl in the protein present in the inclusion bodies. Similar results
were obtained with an additional experiment.
Therefore, adding 0.25% sarkosyl, an ionic detergent, helped in solubilizing most
of the expressed GST-PSP-V5 fusion protein into the supernatant.
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Figure 8: Solubilization of GST fusion protein.
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Figure 8: GST-rPSP-V5 bacteriallysates treated with sarkosyl (0-1.5%) were
centrifuged. 4X SDS-PAGE buffer was added to the pellet. Equal volumes of samples
were electrophoresed on SDS-PAGE and later transferred to PVDF membrane for
western blotting. The membrane was probed with anti-V5 antibody. Lanes 1 to 5: Band at
50 kDa is GST-rPSP-V5. M: Molecular size marker.
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Figure 9: Effect of sarkosyl on solubilizing protein from inclusion bodies.
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Figure 9: To study the effect of solubilization of protein with the effect of sarkosyl, ROIs
of the band were recorded from the western blot (Figure 8) on the Kodak ImageStation
and were plotted against the % of the sarkosyl added. There is a 6-fold decrease in the
amount of protein present in inclusion bodies from 0% to 0.25% Sarkosyl.
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BINDING OF GST-FUSION PROTEIN TO GLUTATHIONE SEPHAROSE 4B

In order to partially purify the GST-PSP fusion proteins, glutathione Sepharose
4B affinity beads were utilized. The glutathione ligand on the glutathione Sepharose 4B
is coupled via a 10-carbon linker to the Sepharose beads. The coupling is optimized to
give a high binding capacity for GST-fusion proteins. GST fusion proteins can be
purified directly from bacterial lysate using Glutathione Sepharose 4B by affinity
purification. Binding of GST-PSP-V5 was tested by incubating a fraction of the lysate
obtained by sonication of the bacterial culture, with 50% (v/v) slurry of glutathione
Sepharose 4B. To show a specific interaction, one of the tubes had no glutathione, only
Sepharose 4B slurry. This was the negative control in the experiment as the GST tagged
protein should bind only to the beads containing glutathione and not to the Sepharose.
The mixture was centrifuged at 1000 x g for 1 min. The beads were washed several times
with ice cold PBS and 1 mM PMSP to remove nonspecifically bound protein. At the end
offiye washes, SDS-PAGE buffer was added to the pelleted beads. Samples were
analyzed by a SDS-PAGE (Figure 10), and transferred to PVDP membrane followed by
probing with anti-V5 antibody. The GST-fusion protein bound to the beads was easily
identified as a major band that was absent in lane 1, demonstrating an affinity for"
glutathione Sepharose and not for Sepharose alone.
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Figure 10: Binding of GST-fusion protein with glutathione Sepharose 4B.
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Figure 10: Glutathione Sepharose 4B and Sepharose 4B alone (control) beads with
bound GST-rPSP-V5 protein were centrifuged and SDS-PAGE buffer was added to them
Samples were electrophoresed on SDS-PAGE, followed by western blotting and
probing with anti-V5 antibody. Lane 1: Sepharose 4B alone, Lanes 2-4: Glutathione
Sepharose 4B . M: molecular size marker.
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EFFECT OF TRITION ON BINDING OF GST TAGGED PROTEIN TO

GLUTATHIONE SEPHAROSE 4B
To get maximum binding to the beads, it was necessary to optimize the binding
conditions. It has been reported that adding Triton X-lOa was necessary for maximal
binding of a particular fusion protein to the beads [55]. However, the effect of Triton
varies with different proteins. Keeping this in mind, an experiment was performed with
different amounts of Triton, ranging from a -1 %, added to the binding reaction. Figure
11 displays a western blot probed with anti-V5 antibody. Bacterial lysate was aliquoted
into small fractions, and different percentages of Triton were added. After incubating the
lysate with the glutathione Sepharose 4B slurry at 4°C and a quick spin, the protein
bound to the beads was stripped off by SDS-PAGE buffer and analyzed by western blot.
The amount of protein bound to the beads did not increase significantly on adding Triton.
Therefore, Triton was not helpful for purifying GST-PSP-V5 and was not incorporated in
the binding buffer.

EFFECT OF TEMPERATURE ON BINDING
Temperature has great effect on the binding of GST tagged fusion proteins to the
beads. Both 4°C and 28°C have been proven to increase the binding efficiency [56], [53].
To optimize the binding temperature, GST-rPSP-V5 was incubated with glutathione
Sepharose 4B slurry at 4°C or at room temperature (26°C). A fraction ofthe sonicated
lysate was mixed with the beads and incubation was done with end to end mixing at 2
different temperatures. The mixture was centrifuged at 1000 x g for a minute. Both bound
and unbound fractions were analysed by SDS-PAGE. To the beads, 4X SDS-PAGE
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buffer was added to elute the bound protein. Figure 12 is a western blot probed with antiV5 antibody. It can be seen from the figure that room temperature incubation did not
have a significant effect on the amount of protein bound to the beads when compared to
protein bound to beads at 4°C incubation.
These two sets of experiments were repeated three times, and it was concluded
that adding Triton to the binding reaction, or incubating at room temperature did not
significantly increased the amount of GST-PSP-V5 fusion protein bound to the beads.

37

.Figure 11: Effect of Triton on binding

1

2

3

4

M

.
GST-rPSP-VS

o

0.2S

O.S

1.0

% of Triton X-I00

Figure 11: Western blot of GST-rPSP-VS bacterial lysate treated with different
,

percentages of Triton during the affinity binding reaction, probed with anti-VS aritibody.
The binding reaction was carried out at 4°C. Addition of Triton does not increase the
amount of protein isolated. Lane 1-4: different percentages of Triton. M: molecular size
marker.
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Figure 12: Effect of Triton and temperature on binding
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Figure 12: Western blot of Trition-treated GST-rPSP-V5 bacteriallysates bound to the
beads at two different temperatures (4°C and room temperature). The blot was probed
with anti-V5 antibody. Lane 2-5: 0% Triton added to the binding reaction. Lane 6-9:
0.25% Triton added to the binding reaction. Lane 2, 4, 6, 8: GST-PSP-V5 protein. bound
to the affinity beads. Lane 3, 4, 7, 9: Unbound protein. Lane 1: starting sample that went
on to the beads. M: molecular size marker.
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ELUTION OF THE GST FUSION PROTEIN
The next goal was to optimize the conditions for elution of GST-PSP-V5 protein
from the glutathione Sepharose beads using reduced glutathione. As per the standard
elution protocol given by GE healthcare, the elution buffer consisted of 50 mM Tris-HCI,
10 mM reduced glutathione, pH 8.0, and 1 to 10 mM DTT. Three different concentrations
of reduced glutathione were tested (5 mM, 10 mM and 15 mM). After 1 hour incubation
at room temperature the beads were collected by centrifugation and the eluted protein
was loaded on a SDS-PAGE. After electrophoresis the gel was transferred to PVDF
membrane and probed with anti-V5 antibody (Figure 13). The GST-rPSP-V5 protein was
eluted with the correct band size of 50 kDa. 15 mM reduced glutathione eluted a fairly
good amount of protein.

PROTEASE CLEAVAGE OF PURIFIED GST-rPSP
The GST vector system is designed to allow cleavage of the fusion protein,
releasing the protein of interest and leaving the GST protein bound to the glutathione
Sepharose beads. After incubating the GST-rPSP-V5 with the beads, and washing the
beads well with PBS and 1 mM PMSF, the enzyme thrombin was added to the protein
bound to the beads. For the enzyme reaction, 200 J.lL of the affinity beads were used with
100 J.lL of PBS buffer containing 20 units of thrombin (as per the manufacturer), and
incubation was done at room temperature for 4 hours. Aliquots were taken after 2 hours
and 4 hours of incubation. SDS-PAGE buffer was added to the beads left behind to strip
off the uncleaved protein. Samples were analysed by SDS-PAGE and western blotting. In

Figure 14, the majority of the GST-PSP-V5 protein is not successfully cleaved by
thrombin, and remains bound to the glutathione Sepharose beads (lanes 2 and 4). A
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separate experiment was carried out in which the protein bound to the beads was
incubated with thrombin for 16 hours. No significant increase in the amount of protein
cleaved was observed in the 16 hour incubation. Even when glutathione was used to elute
the GST-PSP-V5 fusion protein from the beads prior to treatment with thrombin, very
little cleaved PSP was obtained (not shown). All these experiments lead to the conclusion
that Thrombin is very ineffective in cleaving the GST-PSP-V5 protein. This may be due
to folding of the protein in a way that conceals the cleavage site.
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Figure 13: Elution of GST fused rPSP bound to glutathione beads.
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Figure 13: Western blot of the glutathione eluted GST-rPSP-V5 protein. Elution was
tested with three different concentrations of reduced glutathione. Samples were analysed
on SDS-PAGE followed by western blotting and were later probed with anti-V5
antibody.
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Figure 14: Protease cleavage of GST -rPSP-VS.
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Figure 14: Thrombin treated GST-rPSP-V5 protein were electrophoressed on SDSPAGE followed by western blotting and probing with anti-V5 antibody. Lanes 1 and 3:
protein eluted (E) from the beads by Thrombin digestion after the cleavage. Lane 2 and 4:
remaining Bound (B) on the glutathione Sepharose beads.
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INDUCTION AND PURIFICATION OF pGEX 6 P-l-rPSPdss attB V5
Since the rPSP protein was not successfully purified using thrombin, the rPSP
cDNA was cloned into a different GST vector containing the PreScission protease
cleavage site. The pGEX-6P Expression Vectors permit site-specific cleavage and
simultaneous purification on Glutathione Sepharose beads. PreScission Protease is a
genetically engineered fusion protein consisting of human rhinovirus 3C protease fused
to GST. This protease was specifically designed to facilitate removal of the protease by
allowing simultaneous protease immobilization and cleavage of GST fusion proteins
produced from the pGEX-6P vectors. Because PreScission Protease has been engineered
with a GST tag, it binds to the glutathione beads and can also be removed from the
cleavage mixture.
To test the expression of GST-2-rPSP-V5 and GST-2-V5, induction was done
similarly as with pGEX 4T-3 expression vector. An overnight culture was diluted 1:5 in
fresh medium, incubated until the optical density reached 0.8, and was further induced
with 0.1 mM IPTG. As every expression vector acts in a different manner, the induction
was carried for 4 hours and aliquots (20 ilL) of bacterial culture was taken after hour to
check the amount of protein expressed. Before adding the IPTG, an aliquot was taken as
the uninduced sample (negative control). All the samples were analysed by SDS-PAGE.

Figure 15 is a western blot probed with anti-V5 antibody. As can be seen in lanes 1 and
5, there is no expression of protein in the uninduced samples (before adding IPTG).
Lanes 2,3 and 4 show the expression of full length GST-2-rPSP-V5 protein (50 kDa).
Lanes 6,7 and 8 show expression of GST-2-V5 protein (no insert; 26 kDa) [57]. Hence
the constructs do express the correct size proteins.
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Also, comparing the amount of protein expressed over a period of hours, no
significant increase was observed when 2 hours was compared with 4 hours. Therefore, I
decided to keep the induction time as 2 hours.
The expressed fusion proteins were characterized as described above. Figure 16
shows glutathione elution of GST-2-rPSP-VS or the GST-2-VS. The samples were
analyzed by western blotting. The membrane was probed with three different antibodies
to characterize the expressed proteins (anti-VS antibody, anti-PSP antibody, anti-GST
antibody). It can be seen from the figure that the eluted GST-2-rPSP-VS in lanes 1 and 3
show the correct size protein when probed with all three antibodies. The eluted GST-2VS protein (lane 2) did not show any immunoreactivity when probed with anti-PSP
(Figure 16 B), but bands were observed when probed with anti-VS antibody and anti-

GST antibody (Fig. 14A&C). Therefore, the expressed proteins were of the expected
sizes and the expected immunoreactivities.

45

Figure 15: Induction of GST -2-rPSP- VS and GST -2- VS.
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Figure 15: IPTG induced and uninduced bacterial samples were elelctrophoressed on a

SDS-PAGE. It was then electro blotted and probed with anti-V5 antibody. Lane 1 and 5:
uninduced sample; lane 2,3 and 4: GST-2-rPSP-V5; lane 6,7and 8: GST-2-V5; M:
Molecular size marker.
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.Figure 16: Characterization of expressed GST-2-rPSPdss-VS.
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Figure 16: The glutathione eluted GST-2-rPSP-V5 samples were analysed on a SDSPAGE followed by western blotting. The membrane was probed with three different
Antibodies. (A) : anti-V5 antibody, (B): anti-PSP antibody, (C): anti-GST antibody. Lane
1, 3- glutathione eluted GST-2-rPSP-V5 ; lane 2: glutathione eluted GST-2-V5 (without
the rPSP insert). M: Molecular size marker.
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OPTIMIZING THE CONDITIONS FOR AFFINITY BEADS
The next goal was to use silver-staining to help maximize the level of purity of
the eluted protein. For this purpose aliquots were taken from each purification step, and
proteins separated by SDS-PAGE. The gel was silver stained to detect all the major
proteins present. In a silver stained gel multiple bands of protein were observed in the
glutathione eluted protein (Figure 17). Therefore, additional steps for washing the
affinity beads were investigated. It has been reported that the peptide region between
GST and the fusion protein often binds E.coli DnaK, the bacterial Hsp70 (Heat shock
protein 70) molecular chaperone homolog, resulting in an unwanted copurification of the
chaperone with the fusion protein [58]. However, washing the fusion protein bound to the
beads with MgS0 4 , ATP, and denatured E. coli lysate before eluting the beads decreases
copurification of the unwanted protein [58, 59].
Several different washing conditions were tried. The IPTG induced bacter.ial
pellet ofpGEX 6P-l-rPSPdss-V5 was sonicated and 1.5 mL of the bacterial lysate was
bound to the glutathione Sepharose affinity beads (in each of 5 separate tubes), and
incubated at 4°C for the binding reaction. The tubes were centrifuged and the bound
protein and beads were washed with different buffers. The washed beads were incubated
with the glutathione elution buffer for an hour at room temperature. The eluted proteins
(1.5 ug) from each tube were analyzed by SDS-PAGE, and made visible by silver
staining. In Figure 17, lanes 3-7 are the glutathione eluted proteins isolated after
different washing conditions. Comparison of the starting lysate (lane 1) to the eluted
samples (lanes 3 -7) shows that affinity binding provides a dramatic purification of the
GST-2-rPSP-V5 protein. The full-length GST-2-rPSP-V5 fusion protein is an abundant
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protein in the eluate (based on the apparent molecular size). Nonetheless, additional
proteins are present. Washing the affinity beads with A TP, MgS04 and denatured E. coli
protein removed the approximately 80 kDa proteins, consistent with the possibility that
these are DnaK -related proteins. This improved the relative purification. An additional
smaller protein of about 28 kDa was present in the eluted fraction. This may be a Cterminal fragment of the GST-PSP-V5 fusion protein, and is discussed below.

.
Due to the improved purification, the washing conditions were modified for all
subsequent experiments. They are as follows:
a. To keep the protein degradation minimal the entire purification experiment was
performed at 4° C and protease inhibitors were added to the washing buffer.
b.

The ionic strength was increased by adding NaCI to the washing buffer.

c. ATP, MgS04 and denatured E.coli protein were added to one wash buffer to
decrease the copurification of the putative DnaK protein.
d. The volume ofthe washing was increased to 1.5 mL for 200 ilL of the beads. Also
the washing was done for 10 minutes with end to end mixing of the washing
buffer and the beads.
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Figure 17: Effect of A TP on protein purification
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Figure 17: It is a silver stained gel. Aliquots from purification procedure were loaded on

4-12% SDS-PAGE and were electrophoressed. After electrophoresis the gel was silver
stained. Lane 1: bacterial lysate (starting sample) (13 ug) ; Lane 2: protein left on the
beads after elution (3ug); Lane 4-7 GST-2-rPSP-V 5 glutathione eluted protein; Lane 3:
150 mM NaCI in the washing buffer; Lane 4: 500 mM NaCI in the washing buffer; lane
5: 10% glycerol added to the washing buffer; Lane 6: ATP, MgS04 and denatured E.coli
protein added to the washing buffer; Lane 7: ATP, MgS04 and denatured E.coli protein
added to the bacterial lysate. Lane 8: GST-2-V5 eluted protein.

* The lower size band (28 kDa) could be there due to proteolytic cleavage of C terminal
of the fusion protein.
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With the additional washing steps, few contaminating proteins were present after affinity
purification. However, smaller proteins which were immunoreactive with anti-VS
antibody were present, and were judged to be C-terminal fragments of the GST -2-rPSPVS protein. The stability of fusion proteins can be increased by reducing the temperature
of incubation during IPTG induction. Therefore, IPTG induction of GST-2-rPSP-VS was
tested at two temperatures and two IPTG concentrations. Figure 18 is a silver stained
SDS-PAGE of affinity purified protein induced under different conditions. Improved
expression of the full-length fusion protein was obtained at 26°C with 1 mM IPTG. Thus
lowering the induction temperature and increasing the IPTG concentration produced
more active GST-2-rPSP-VS.
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Figure 18: Changing the IPTG induction temperature
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Figure 18: The glutathione eluted protein from all the induced pellets were loaded on 412% SDS-PAGE for electrophoresis followed by silver staining. Lane 1 and 2: Bacterial
culture induced at 37°C, Lane 3 and 4 : Bacterial culture induced at room temperature
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PRE SCISSION PROTEASE CLEAVAGE
While the Thrombin cleavage did not produce useful rPSP protein (Figure 14),
the newer clone in pGEX 6P is designed to cleave the rPSP from GST using PreScission
Protease enzyme. An initial experiment tested the utility of PreScission protease. Three
aliquots of 1.5 mL bacterial lysate were incubated with 200 ilL of glutathione Sepharose
4B beads for an hour. The protein bound to beads was washed as described above.
Glutathione elution buffer (200 ilL) was added to one tube and was incubated for an hour
at room temperature. The other two tubes were then equilibrated with the cleavage buffer
(50 mM Tris pH 7.0, 150 mM NaCI, 1 mM EDTA, and 1 mM DTT). The protein bound
to the beads was thoroughly washed for 10 min with end to end mixing at 4 DC followed
by a quick spin. Fusion protein bound to 200 ilL of affinity beads was incubated with 16
units (8 ilL) of enzyme resuspended in 192 ilL of the cleavage buffer. The optimum
temperature for cleavage is 4 DC. Incubation time varies from protein to protein, and it
ranges from 4 to 16 hours. The beads were incubated with the enzyme at 4 DC with end to
end mixing. After 4 hour incubation, one tube was centrifuged for 45 min at 500 x g. The
other tube was centrifuged after 16 hour of incubation. The PreScission protease eluted
protein from both the tubes and the glutathione eluted protein were analyzed by SDSPAGE and western blot. Figure 19 is a western blot probed with anti-V5 antibody. The
glutathione-eluted control (lane 1), shows the expected size of the GST-2-rPSP-V5 fusion
protein. Pre Scission protease-eluted protein (lanes 2 and 3) shows an additional
prominent protein slightly smaller than 30 kDa, which is the expected size for rPSPdssV5. Incubation with the PreScission enzyme for 16 hours did not increase the amount of
cleaved protein.
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Figure 19: PreScission protease cleavage of GST-2-rPSP-V5
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Figure 19: To one fraction of the glutathione beads bound with GST-2-rPSP-V5 ,
glutathione elution buffer (15 mM) was added and to another two fractions 16 units of
PreScission protease enzyme was added and were incubated for 4 hours and 16 hours
respectively. Lane 1 is the glutathione eluted protein, lanes 2 and 3: PreScission Protease
eluted protein.
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PROTEIN-LIPID OVERLAY ASSAY

The above results demonstrate that this protocol produces a relatively
purified preparation ofrPSP-VS. To study the specific binding ofrPSP-VS to lipids, this
bacterially expressed and purified protein was used. The binding studies were done using
protein-lipid overlay assays [60]. The experimental designs are very similar to that used
to study other PtdlnsP-binding proteins [34, 37]. The specificity of binding ofrPSP-VS to
Ptdlns(3,4)P2 is clearly demonstrated in Figure 20. Affinity purified, PreScission-eluted
rPSP-VS protein (l1lg/mL) was incubated for 1 h with a nitrocellulose membrane spotted
with serial dilutions (200, 100, SO, 2S, 12.S, 6.2S pmol) of each of the following lipids:
Ptdlns, Ptdlns(3)P, Ptdlns(3,4)P2, Ptdlns(3,S)P2, Ptdlns(4,S)P2 and Ptdlns(3,4,S)P3. After
washing, the binding was detected by probing the membrane with anti-VS antibody.
rPSP-VS bound to as low as 6.2S pmol ofPtdlns(3,4)P 2, but did not bind with similar
affinity to any other phosphoinositides. Thus rPSP-V S has specific binding affinity for
Ptdlns(3,4)P2. The relative optical intensities (ROls) for all the spots indicating the
amount of protein bound to the phosphoinositides were recorded from Figure 20. Figure
21 shows that the binding ofrPSP-VS was maximum to Ptdlns(3,4)P2, followed by

Ptdlns(3,4)P 2, Ptdlns(4,S)P 2 , Ptdlns(3,4,S)P3 and there was no binding visible with
Ptdlns(3)P and Ptdlns. This data shows rPSP directly bound to Ptdlns(3,4)P2 as it is a
purified protein. Also there being a selective binding of PSP to particular PtdlnsPs, which
must be mediated by interactions with the different headgroups of the lipids. The proteinlipid overlay assays were performed twice for both GST-rPSP-VS and rPSP-VS.
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Figure 20: Phosphoinositide binding properties of rPSP-V5
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Figure 20: Lipid binding properties of rPSP-V5 were analysed by a protein-lipid overlay

assay. 1 Ilg/mL of rPSP-V5 protein was incubated with the nitrocellulose membrane
spotted with serial dilutions of different phosphoinositides. The membrane was washed in
PBST and protein bound to lipid spots on membrane was detected by anti-V5 antibody.
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Figure 21: Relative Binding of rPSP-VS to different Phosphoinositides
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Figure 21: Relative optical intensities were recorded from the Protein-lipid overlay

assay (Figure 20) using the Kodak imagestation and were plotted as a bar graph with the
different phosphoinositides spotted on the nitrocellulose membrane.
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The above experiments demonstrated strong binding ofrPSP-VS to Ptdlns(3,4)P 2
compared to other PtdlnsPs. A protein-lipid overlay assay was done for only
Ptdlns(3,4)P2 and Ptdlns (Figure 22). Serial diltuions (200, 100, SO, 2S, 12.S, 6.2S pmol)
of both the lipids were spotted on a nitrocellulose membrane and incubated with 1 llg!mL
ofrPSP-VS. The relative optical intensities recorded from the bound protein were
analysed on the Graph Pad Prism as binding curve. Figure 22 shows the binding curve
which is representative of six experiments. These data suggest half maximal binding at
less than SO pmollipid, indicating strong binding. Further experiments were done to
quantify the binding affinity ofrPSP-VS to Ptdlns(3,4)P2.
Quantify the Binding affinity (Kd) ofrPSP-VS to Ptdlns(3,4)P2 •
Different concentrations ofrPSP-VS ranging from 0.1 Ilg/mL to 3.S Ilg/mL were
incubated with nitrocellulose membrane spotted in duplicate with SO pmol of
Ptdlns(3,4)P2 and Ptdlns. After 1 hour incubation, an aliquot of the incubation solution
was taken to directly measure the free rPSP-VS protein available. Free protein was
spotted on the nitrocellulose membrane, and air dried. Bound rPSP-VS on the membrane
was washed, and quantified by probing with anti-VS antibody. To create a standard curve
for rPSP-VS, known amounts ofrPSP-VS (.0002S ug to O.lug) were spotted on a
nitrocellulose membrane (Figure 23 B). rPSP on all the membranes was quantified by
using anti-VS antibody. Relative optical intensites of spots on all the membranes were
recorded from the Kodak imagestation and the amount of free and bound protein was
calculated using the standard curve (Figure 24 B). A Kd value was calculated using
Graph Pad Prism version S.Ol using the equationy = Bmaxx x/(Kd +.A) where Bmax is the
maximal binding, and Kd is the concentration of the ligand required for half - maximal
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binding. The binding curve (Figure 24 A) is a non linear regression fit using One SiteSpecific Binding as the parameter. A Kd of 3 x 10-1 I M was obtained, representing an
average of three consecutive experiments.
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Figure 22: Protein-lipid overlay assay: Different concentration of Ptdlns(3,4)P2
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Figure 22: A: A protein-lipid overlay assay with serial dilution ofPtdIns(3 ,4)P 2 and

PtdIns. Protein bound to the membrane by interaction with lipid was detected by Anti-V5
antibody. ROIs were recorded on the Kodak imagestation and were analysed on Graph
Pad Prism version 5.01. B: The Binding curve represents a non linear regression curve
accounting for One Site- Specific Binding.
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Figure 23: Protein-lipid overlay assay: Different concentration of rPSP-V5
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Figure 23: The PreScission protease eluted protein were incubated with the

nitrocellulose membrane spotted with Ptdlns(3,4)P 2 and Ptdlns (50 pmol) in duplicates.
B: Serial dilution ofrPSP-V5 was spotted on the membrane for obtaining a standard
curve. All the membranes were incubated with Anti-V5 HRP antibody (1 :5000) dilution
and their ROls were recorded on the Kodak image station.
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Figure 24: Binding Curve for Ptdlns(3,4)Pz binding to rPSP-VS

A
Ptdlns(3~4)P2

binding to rPSP-V5

0.5

u;
~ 0.4

~

=Q 0.3

c

:=

~ 0.2

.2

:=

~ 0.1
c.

II)

O.O~------r----........,r--------.

o

50

100

150

Free Protein (pM)

B

Standard Curve for rPSP-V5
800000
600000

5a::

400000
200000

o

~-----------------------------

a

0.02

0.04

0.06

0.08

0.1

rPSP-VS (ug)

Figure 24: Different concentrations of protein were incubated with 50 pmol of
Ptdlns(3,4)P2 and Ptdlns. The data were obtained by measuring the relative optical
intensity for each spot in figure 19, and specific bound protein and free protein were back
calculated using the standard curve (B). The binding curve (A) has been derived using the
equation y =

Bmax

xXI(Kd+ X) where Bmax is the maximal binding and Kd is the

concentration of ligand required for half-maximal binding.
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PURIFICATION AND BINDING OF p47 phox to PtdIns(3,4)P 2
A well known Ptdlns(3,4)P 2 binding protein was used to directly compare its
binding activity to rPSP. The reported affinity for P47 phox is 2.6 x 1O-6 M [34, 40]. The
plasmid pGEX 4T-l-p47 phox (aa2-132) (Addgene) was transformed into BL-21 competent
cells. Also the p47 phox cDNA was cloned into pGEX 6P-l with a V5 tag (GST-2-p47phoxV5) added to it. Both GST-p47 phox and GST-2-p47phox-V5 were induced with 1.0 mM
IPTG for 5 hours at room temperature. The protein was purified using the same method
used for GST-rPSP-V5 purification. Affinity purified glutathione eluted protein from
GST-p47 phox was loaded on 4-12% SDS-PAGE. Figure 25 (At) is the western blot
probed with anti-GST antibody (1 :500) dilution. The 40 kDa size band is GST-p47 phox.
Figure 25 (A2) is the silver stained gel of the glutathione eluted protein showing a single
protein. Therefore, the protein purification protocol optimized for rPSP was successful in
purifying the GST-p47phox. GST-2-p47phox-V5 protein was affinity purified and cleaved
with Prescission protease enzyme to obtain p47phox-V5 protein. To compare the binding
ofrPSP-V5 to GST-p47 phox, a protein-lipid overlay assay was done. Figure 25 B shows
nitrocellulose membranes spotted with serial dilutions ofPtdIns(3,4)P2 and PtdIns. They
were incubated with 3

~g/mL

ofGST -2-rPSP-V5 and GST-p47 phox-V5 fusion proteins.

One membrane was incubated with GST-V5 alone (negative control). Binding of the
protein to the lipid was detected by anti-GST antibody. The figure shows that GSTp47phox does not bind as strongly to PtdIns(3,4)P2 as compared to GST-2-rPSP-V5. In
another experiment, a very high concentration (15 ~g/mL) ofp47hox-V5 was incubated
with the nitrocellulose membrane spotted with 50 pmol ofPtdIns(3,4)P2 . The membrane
was probed with anti-V5 HRP antibody.
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Figure 25 C shows that a higher concentration of GST-p47 phox bound to PtdIns(3,4)P 2
Thus it can be concluded that a rPSP-VS binds strongly to the lipid as compared to
p47 phox.

PURIFICATION AND BINDING OF GST-hPSP-V5 to PtdIns(3,4)P 2
The Human PSP cDNA was cloned into pGEX 4T-3 expression vector and was
tagged with VS. It was transformed into BL-21 cells. The method optimized for
expression and purification of GST-rPSP-VS was used for GST-hPSP-VS. The affinity
purified and glutathione eluted protein was used for studying the binding to PtdIns
.Nitrocellulose membrane were spotted with 100 pmol of the following lipids- PtdIns,
PtdIns(3,4)P2, PtdIns(3,S)P2 and PtdIns(4,5)P 2. They were incubated with 1 Ilg/mL of
GST-rPSP-VS, GST-hPPS-VS fusion proteins. GST-VS was used as a negative control.
The membranes were probed with anti-VS antibody and the binding signal was detected
on the Kodak image station. Figure 26 shows that GST-hPSP-VS bound to PtdIns(3,4)P2 ,
but the relative optical intensity of the bound GST-hPSP-VS protein was less than GSTrPSP-VS bound protein P. GST-hPSP-VS bound specifically to the phosphorylated forms
of Phosphotidy linos ito I and no binding was seen with PtdIns.

64

Figure 25: Purification and Binding of GST -p47phox
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Figure 25 - 3ug of affinity purified and Glutathione eluted GST-p4 7phox protein was
loaded on the 4-12% SDS-PAGE. Al is the western blot probed with anti-GST antibody
(1 :500) dilution, and A2 is the silver stained gel showing the purified

GST-p47ph~x.

B

shows the protein-lipid overlay assay for GST-rPSP-V5 , GST-p47 phox and GST-V5.
Binding of 3 jlg/mL of the glutathione eluted protein incubated with nitrocellulose
membrane was detected with anti-GST antibody. C shows binding of 15jlg/mL of
p47phox-V5 to Ptdlns(3,4)P2 on a nitrocellulose membrane detected with anti-V5 HRP
antibody.
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Figure 26: Binding of GST -hPSP-V5 to Ptdlns(3,4)P2
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Figure 26: 1 Ilg/mL of GST fused rPSPdss and hPSPdss were incubated with the

nitrocellulose membrane spotted with different PtdlnsPs (100 pmol). The binding of the
protein to the lipid was detected by Anti-V5 antibody. GST-V5 was used as a negative
control.
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DISCUSSION
PAROTID SECRETORY PROTEIN
Parotid Secretory Protein (PSP) is one of the most abundant proteins present in
saliva secreted from rat parotid gland [61, 62]. Rat PSP is the homologue of mouse PSP
[63]. It is a 23 kDa leucine rich protein [64, 65]. It is present in immature acinar cells,
seen as soon as the first postnatal week and increasing by 21 days to the high adult level
[62].
PSP is a member of the Palate Lung-Nasal epithelium clone (PLUNC) gene subfamily within the larger BPI family of mammalian proteins that include bactericidal
permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP) [2].
BPI and LBP are two key members of the innate immune response to Gram negative
bacteria. LBP and BPI are crucial in host defense against gram negative bacteria [66].
The amino acid sequences of Palate Lung-Nasal epithelium clone (PLUNC) proteins are
similar BPI anci LBP [66-68]. PLUNCs are largely expressed in the upper respiratory
tract and oral cavity thereby serving a role in host defense [66-68]. The PLUNC family
has been divided into short PLUNC (SPLUNC) and long PLUNC (LPLUNC) proteins.
SPLUNC 2 is the human orthologue of rodent PSP with 22% similar and 52% identical
protein sequence[69]. Like rat PSP, SPLUNC2 is expressed predominantly in parotid and
submandibular glands. It has also been shown to be produced by minor salivary glands
[69]. Its presence in whole saliva has been reported by many proteomic studies [70].
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Thus considering its genomic location, sequence and expression patterns of SPLUNC 2,
it is clear that this gene product is human PSP. Western analysis shows that multiple
isoforms of SPLUNC2 (hPSP) are present in saliva. This could be due to differential
glycosylation of the protein [69]. These multiple isoforms could exhibit different
properties.
PURIFICATION OF PROTEIN
The initial goal for the thesis was to express and purify rat PSP in well known
expression system, Escherichia coli (E.coli) [71, 72]. rPSP was first made into a cDNA
fusion clone with an affinity tag (Glutathione-S-transferase) present in the pGEX'vector.
Affinity tags can increase the yield of protein [73], increase the protein solubility [74],
help in purifying the protein [75], and decrease proteolysis of protein. There are several
fusion tags available, including polyhistidine tags [76], FLAG tags [77], thioredoxin,
Protein A, strep tag and maltose binding protein [76]. Glutathione-S-transferase [53] has
been widely used as a fusion tag for protein expressed in E.coli. The rPSP cDNA was
inserted into pGEX vector system containing the GST tag. Two expression vectors pGEX
4T and pGEX 6P-1 were tested for the expression and purification of protein. The protein
purification protocol was first optimized for rPSP inserted into pGEX 4T-3 vectot. An
epitope tag (V5) was included at the end ofPSP to provide an easy way to detect the
expressed protein. Protein induction was carried out with O.1mM IPTG.
Glutathione-S-transferase is a 26 kDa protein [57] and the expressed GST-rPSP-V5
fusion protein is a 50 kDa protein. On analyzing the western blot probed with anti-V5
antibody the correct band size of protein was seen (Figures 5, 6). Often protein expressed
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in bacteria is insoluble and is seen present as inclusion bodies [78, 79]. Inclusion bodies
contain insoluble aggregates of the recombinant protein. Ionic and non -ionic detergents
have been shown to solubilize certain proteins into the supernatant without affecting
binding to the glutathione beads [54]. Adding as little as 0.25% sarkosyl to the cell lysis
buffer was able to completely solubilize one GST fused protein [55]. Different
concentrations of sarkosyl were tested, and 0.25% sarkosyl was the lowest concentration
which was able to solubilize the GST-PSP fusion (Figures 18,19). pGEX expression
vectors have specific protease cleavage sites incorporated in them. A thrombin cleavage
site is encoded in the pGEX 4T vectors to enable the separation of the GST tag from the
fused protein. Several experiments were performed to optimize the cleavage conditions
but these were not successful in cleaving the GST tag from rPSP without allowing
degradation of the PSP (Figure 14). This led to cloning rPSP cDNA into a different
expression vector pGEX 6P, which has a PreScission protease cleavage site. Several
changes were made in the protein purification protocol. To reduce the low molecular
weight impurities, the induction temperature of the plasmid pGEX 6P-I-rPSPdss-attB
was reduced from 37° C to room temperature as it increased the stability of the fusion
protein (Figure 18) [80]. When the protein was eluted from the glutathione beads, and
analysed on SDS-PAGE by silver staining, a 70 kDa contaminant was observed which
was identified as the chaperone protein Dnak. It has been observed that Dnak (an
abundant protein in E.coli, about 1%) [81] often binds to the connecting peptide regions
and copurifies with the fusion protein. These biological impurities can interfere with the
future studies involving the protein. Dnak contamination was minimized by washing the
protein bound to beads with MgATP [58, 82] and denatured E.coli protein [58]. When
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Dnak is bound to A TP its affinity for the protein decreases [83]. After incubating the
GST-rPSP-V5 lysate with the glutathione-Sepharose bead, the beads were washed three
times with ATP, MgS04 and denatured E. coli protein, followed by incubating the beads
with the elution buffer (Figure 17).
It was then required to cleave the rPSP cDNA insert from the GST tag. As the

pGEX 6P-l expression vector are engineered with a Pre Scission Protease cleavage site,
the Pre Scission enzyme was added to the binding reaction. IOU of the enzyme for every
0.1 mL of glutathione epahrose column was sufficient to remove the GST tag (Figure
19). The concentration of the rPSP-V5protein obtained after cleavage was 90 Ilg/mL.

PSP BINDS SPECIFICALLY TO PtdIns(3,4)P 2 WITH A HIGH AFFINITY
Binding studies were done using GST-rPSP-V5 and rPSP-V5 alone. Both of these
expressed rPSP proteins showed strong binding to Ptdlns(3,4)P2. GST-V 5 alone did not
show binding to either PtdlnsPs or to Ptdlns suggesting that the binding was specific for
rPSP. From the protein overlay experiments where binding to all PtdlnsPs were tested

(Figure 20), we observed a 10-fold higher binding ofrPSP to Ptdlns(3,4)P2 compared to
Ptdlns(3,5)P2 or Ptdlns(4,5)P2 and minimal binding to Ptdlns(3)P (Figure 21).
Maximum binding was seen with Ptdlns(3,4)P2 followed by Ptdlns(3,5), Ptdlns(4,5) and
Ptdlns(3,4,5)P3 in decreasing order. There was no binding observed to unphosphorylated
Ptdlns. This suggests that PSP specifically binds to Ptdlns(3,4)P2. This also shows that
PSP interacts with inositol head group since identical lipid chains are present in Ptdlns
(which is not bound) as in Ptdlns(3,4)P2 (which is bound by PSP). The virtual absence of
PSP binding to Ptdlns(3,4,5)P3 or to Ptdlns(4,5)P2 shows that the interaction is NOT due
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to non-specific inonic interactions with the charged phosphate groups. This binding
supports the hypothesis that PSP binds directly to PtdIns(3,4)P2 since this was a relatively
purified preparations ofrPSP-V5, and no other mammalian proteins were present.
On testing the binding to different amounts of lipids, it was seen that PSP-V5
bound to as little as 6.25 pmol ofPtdIns(3,4)P2 (Figure 20) which is consistent with
other PtdIns(3,4)P2 binding proteins like TAPPI and p47 phox [37, 40] listed in Table 2.
These proteins bind to PtdIns(3,4)P2 through specific lipid binding domains like PH or
px. The pH for all the binding experiments was kept constant at 7.0 and rPSP bound
specifically to PtdIns(3,4)P 2 at this pH. In the parotid gland, the pH of the granule
increases from pH 6.0 at trans-Golgi network to above pH 6.8 after maturation [84]. Thus
interaction ofrPSP to PtdIns(3,4)P2 at this pH range is consistent with binding in vivo.
Binding studies with human PSP showed specific binding for PtdIns(3,4)P 2 but
with weaker binding when compared to rPSP (Figure 26 ). Human PSP did not bind to
unphosphorylated PtdIns, but did bind strongly to PtdIns(3,4)P2 . There was distinctly less
binding to PtdIns (3,5)P2 and PtdIns(4,5)P2. The sequence of human PSP is onlt 52%
identical to rat PSP (Figure 27).This low level of similarity would suggest that the
structures of rat and hyman PSPs have diverged duting evolutions, yet we find that both
human PSP and rat PSP bind to PtdIns(3,4)P2 specifically. This is the first demonstration
of Human PSP binding to phospholipids. This demonstrates the conservations of function
between rat and human PSP.
Protein-lipid overlay assays were used to estimate the binding affinity (Kd) of
rPSP for PtdIns(3,4)P2. Incubations were done with a broad range of concentrations of
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rPSP-V5. The amounts of bound and free protein were directly measured and the data
was analysed on Graph Pad prism software version 5.01. The Binding affinity (Kd) was
calculated, using a non-linear regression curve fit and the data was analyzed for One site Specific Binding (Figure 24). In three consecutive experiments, the calculated affinities
ranged from 1.85 x 10- 10 to 3 X 10-11 M (Table 4). The Kd value determined for rPSP-V 5
(30 pM) using the lipid overlay assay indicates stronger binding than the Kd values
reported for two other PtdIns(3,4)P 2 specific binding proteins: p47 phox (2.6 uM) and
TAPP 1 (1.5 nM) (Table 3). Thus, these values suggest that PSP is a higher affinity
protein.
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Figure 27: Amino acid sequence comparison ofrPSP and hPSP
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Figure 27: The amino acid identity between rat and human PSPs is very low. Identical
amino acids are highlighted in red. Basic amino acids (R, K) which allow binding to
PtdInsPs are not conserved. Therefore, it seemed unlikely that human PSP could bind
membrane phospholipids as observed with rat PSP.
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This data supports our theory that binding ofPSP to the Ptdlns(3,4)P 2 present at the
vesicle membrane could act as a sorting signal and lead to sorting of PSP into the vesicle.
We included GST-p47 phox in our binding studies. P47 phox is a PX domain protein
binding specifically to Ptdlns(3,4)P 2 . PX domains are specific phosphoinositide-binding
modules, with different PX domains having different phosphoinositide specificity. It has
been suggested that binding ofp47phox to Ptdlns(3,4)P2 in the membrane leads to NADPH
oxidase activation which plays an important role in host defense mechanism of
neutrophils and macrophages [34,40, 85]. The binding affinities of the two proteins were
compared using the protein-lipid overlay assay. The experiments (Figure 25 B) showed
strong binding of GST-2-rPSP-V5 (3 )..lg/mL) to Ptdlns(3,4)P2 and very weak binding of
GST-p47 phox (3 )..lg/mL) to Ptdlns(3,4)P2. 15 )..lg/mL ofp47phox-V5 bound to
Ptdlns(3,4 )P2,(Figure 25C), suggesting that a higher concentration of protein was
required for binding. The reported Kd value for p47 phox (3.8 x 10 -8 M) is more than the
estimated Kd value for rPSP (3.0 x 10- 11 M). Therefore GST-p47 phox does bind to
Ptdlns(3,4)P2 but with a lower affinity as compared to GST-rPSP.
Ptdlns(3,4)P2 is a minor phosphoinositide, comprising only 0.2% of total
PtdlnsP2 [86]. Its interaction with lipid binding proteins mediates an important role in
signaling cascades. Ptdlns(3,4)P2 is present on the plasma membrane being produced
mainly by dephosphorylation ofPtdlns(3,4,5)P3 by action of 5-phosphatases [31].[42].
An important mediator of insulin signaling, PKB (protein kinase B)/Akt binds to
Ptdlns(3,4)P2 via its PH domain[28, 87].

74

Table 2: Specific PtdIns(3,4)P 2 binding proteins
PROTEIN

DOMAIN

REF

TAPP1, TAPP2

PH

[33,37,41-43]

DAPPI

PH

[41]

P47 phox

PX

[38. 39]

Table 3: Reported

~

PI(3,45)P3

GAPI

9 x 10

Ptdlns(3,4,5)P3

GRPI

2.8 xl

[90]

PtdIns(4,5)P2

Dynamin 1

9 x 10

[91]

PtdIns(3,4,5)P3

BtK-PH

8 x 10

[92]

PtdIns(3,4)P2

Akt-PH

3.5 x 10-

[92]

PtdIns(3,4)P2

DAPPI

2.7 x 10-

[92]

PtdIns(3,4)P2

p 47phox

3.8 x 10

[40]

PtdIns(3,4)P2

TAPPI

5 x 10

[37]

values of lipid binding proteins

Table 4: Estimated ~ valued for rPSP
EXPERIMENT NO.

KtI(M)

R2

1

3 03 x 10

9400

2.

3.98 X 10- 11

.9982

3.

1.85 x 1O- 1U

.9938

Average Kd = 2.4 X 10.11 M
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TAPP1 (tandem-Ph-repeat-containing protein-I) binds to PtdIns(3,4)P 2 with its
PH domain and its narrow specificity for PtdIns(3,4)P 2 Ieads to the translocation of the
protein to the plasma membrane [41]. PtdIns(3,4)P2 has been shown to play an important
role in NADPH oxidase activation. TAPPI and p47phoxinteract with the P0 4 groups on
PtdIns(3,4)P2 through basic amino acids (R, K). PSP has R & K, which may allow the
observed binding to PIP.

CONCLUSIONS:
Purified rat PSP showed strong binding with phosphatidylinositol-(3,4)
bisphosphate. Our results strongly suggest direct binding of the PSP to phospholipids
since bacterially expressed and affinity purified protein was used. The extent of PSP
binding is similar to results with TAPP 1 and p4 7phox, which are well characterized
PtdIns(3,4)P2-binding proteins. The Kd value (30 pM) estimated for rPSP shows that it
has a high binding affinity for PtdIns(3,4)P2. These results suggest that the observed
binding of rat PSP to granule membranes may be by a direct interaction with
PtdIns(3,4)P2.
We demonstrate for the first time that human PSP binds to the headgroup of
PtdIns(3,4)P2. The sequence of human PSP is not similar to rat PSP, yet we find that
human PSP does bind PtdIns(3,4)P2 specifically. This is the first demonstration of Human
PSP binding to phospholipids stating that the binding ofrPSP to PtdIns(3,4)P2 is an
important function which has been conserved in humans.
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